Zynerba Pharmaceuticals, Inc. acquired Epygenix Therapeutics, Inc for $680 million.
Zynerba Pharmaceuticals, Inc. completed the acquisition of Epygenix Therapeutics, Inc. on April 30, 2024.
1st Jan change | Capi. | |
---|---|---|
+58.65% | 55.07B | |
-1.94% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+12.09% | 26.28B | |
-21.13% | 18.93B | |
+6.54% | 13.03B | |
+28.19% | 12.26B | |
+25.37% | 12.21B |